$PCVX
Vaxcyte, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Carlos, CA
PCVX chart
What traders are saying about $PCVX
Latest postsVaxcyte, Inc. news
- Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
Yahoo Finance ·
- (PCVX) Risk Channels and Responsive Allocation
Stock Traders Daily ·
- Vaxcyte, Inc. Estimates – NASDAQ:PCVX
TradingView ·
- Vaxcyte slips as investors digest recent financing after Phase 3 vaccine data
Quiver Quantitative ·
- Wall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a Bet
Yahoo Finance ·
- BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push
stocktwits.com ·
- Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Convertible Senior Notes
Yahoo Finance ·
- Why Vaxcyte (PCVX) Is Getting Attention Again
Yahoo Finance ·
- Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
Yahoo Finance ·
- Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers
Yahoo Finance ·
- As Expected: Vaxcyte Announces $1 Billion Stock and Convertible Raise a Day After Its Phase 3 Win (and Sinks 10%)
tikr.com ·
- Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results
qz.com ·
Vaxcyte, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$766,628 | -$463,927 | -$402,266 | -$223,485 |
| Diluted EPS | $-5.63 | $-3.80 | $-4.14 | $-3.44 |
| Total assets (year end) | $3.00B | $3.51B | $1.41B | $1.01B |
| Cash and equivalents (year end) | $174.0M | $387.9M | $397.5M | $834.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Vaxcyte, Inc.
- Ticker
- PCVX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Carlos, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1649094
- Former names
- SutroVax, Inc.
Frequently asked questions
What exchange is Vaxcyte, Inc. listed on?
Vaxcyte, Inc. trades on the Nasdaq under the ticker symbol PCVX.
What industry is Vaxcyte, Inc. in?
Vaxcyte, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Vaxcyte, Inc. headquartered?
Vaxcyte, Inc.'s business address on file with the SEC is in San Carlos, CA.
When does Vaxcyte, Inc.'s fiscal year end?
Vaxcyte, Inc.'s fiscal year ends on December 31.